LMAT Lemaitre Vascular Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LMAT

Price (delayed)

$100.29

Market cap

$2.29B

P/E Ratio

36.34

Dividend/share

$0.9

EPS

$2.76

Enterprise value

$2.45B

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 49
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 91

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, ...

Highlights
LMAT's net income is up by 38% year-on-year and by 8% since the previous quarter
The EPS has grown by 37% YoY and by 8% from the previous quarter
LMAT's quick ratio is up by 12% QoQ but it is down by 12% YoY
The company's debt rose by 2.4% YoY and by 2.3% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.lemaitre.com/
Peers: ANGO BSX EW BAX

Key stats

What are the main financial stats of LMAT

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
-2.38%
1 week
-3.31%
1 month
9.06%
1 year
19.84%
YTD
23.66%
QTD
4.51%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$256.28M
Gross profit
$185.52M
Operating income
$73.06M
Net income
$62.4M
Gross margin
72.4%
Net margin
24.3%
LMAT's net income is up by 38% year-on-year and by 8% since the previous quarter
The operating income has grown by 38% YoY and by 8% from the previous quarter
The company's net margin rose by 22% YoY and by 5% QoQ
The company's operating margin rose by 22% YoY and by 4.8% QoQ

Price vs fundamentals

How does LMAT's price correlate with its fundamentals

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
LMAT P/E details
P/E
36.34
P/B
5.62
P/S
8.92
EV/EBIT
28.61
EV/EBITDA
25.49
EV/Sales
9.58
The EPS has grown by 37% YoY and by 8% from the previous quarter
The P/E is 18% less than the 5-year quarterly average of 44.2
The equity has grown by 17% YoY and by 3.3% from the previous quarter
LMAT's price to book (P/B) is 15% higher than its 5-year quarterly average of 4.9 and 6% higher than its last 4 quarters average of 5.3
The P/S is 16% above the 5-year quarterly average of 7.7 and 7% above the last 4 quarters average of 8.3
Lemaitre Vascular's revenue has increased by 13% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is Lemaitre Vascular business performance
The ROS has grown by 27% YoY and by 4% from the previous quarter
The ROE has grown by 20% YoY and by 3.8% from the previous quarter
LMAT's ROIC is down by 7% year-on-year but it is up by 3.8% since the previous quarter
Lemaitre Vascular's return on assets has increased by 5% QoQ and by 5% YoY

Dividends

What is LMAT's dividend history
Dividend details
DPS
$0.9
Dividend yield
0.9%
Payout ratio
32.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lemaitre Vascular financials performed over time
The company's total assets is 182% higher than its total liabilities
The company's total assets rose by 13% YoY and by 2.2% QoQ
Lemaitre Vascular's current ratio has decreased by 13% YoY but it has increased by 11% from the previous quarter
The company's debt is 53% lower than its equity
The equity has grown by 17% YoY and by 3.3% from the previous quarter
Lemaitre Vascular's debt to equity has decreased by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.